Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 572

1.

The association of palmitoylethanolamide with luteolin decreases neuroinflammation and stimulates autophagy in Parkinson's disease model.

Siracusa R, Paterniti I, Impellizzeri D, Cordaro M, Crupi R, Navarra M, Cuzzocrea S, Esposito E.

CNS Neurol Disord Drug Targets. 2015 Aug 20. [Epub ahead of print]

PMID:
26295827
2.

The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury.

Siracusa R, Paterniti I, Bruschetta G, Cordaro M, Impellizzeri D, Crupi R, Cuzzocrea S, Esposito E.

Mol Neurobiol. 2015 Jul 5. [Epub ahead of print]

PMID:
26143261
3.

Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.

Conte E, Iemmolo M, Fruciano M, Fagone E, Gili E, Genovese T, Esposito E, Cuzzocrea S, Vancheri C.

Expert Opin Biol Ther. 2015 Jul;15 Suppl 1:211-21. doi: 10.1517/14712598.2015.1026804. Epub 2015 Jun 22.

PMID:
26098610
4.

Emerging pharmacotherapy for treatment of traumatic brain injury: targeting hypopituitarism and inflammation.

Paterniti I, Cordaro M, Navarra M, Esposito E, Cuzzocrea S.

Expert Opin Emerg Drugs. 2015 Jun 18:1-14. [Epub ahead of print]

PMID:
26087316
5.

N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.

Skaper SD, Facci L, Barbierato M, Zusso M, Bruschetta G, Impellizzeri D, Cuzzocrea S, Giusti P.

Mol Neurobiol. 2015 Jun 9. [Epub ahead of print]

PMID:
26055231
6.

Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.

Di Cesare Mannelli L, Pacini A, Corti F, Boccella S, Luongo L, Esposito E, Cuzzocrea S, Maione S, Calignano A, Ghelardini C.

PLoS One. 2015 Jun 3;10(6):e0128080. doi: 10.1371/journal.pone.0128080. eCollection 2015.

7.

Role of Toll like receptor 4 signaling pathway in the secondary damage induced by experimental spinal cord injury.

Impellizzeri D, Ahmad A, Di Paola R, Campolo M, Navarra M, Esposito E, Cuzzocrea S.

Immunobiology. 2015 Sep;220(9):1039-49. doi: 10.1016/j.imbio.2015.05.013. Epub 2015 May 11.

PMID:
25990044
8.

Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion.

Impellizzeri D, Bruschetta G, Ahmad A, Crupi R, Siracusa R, Di Paola R, Paterniti I, Prosdocimi M, Esposito E, Cuzzocrea S.

Eur J Pharmacol. 2015 Sep 5;762:136-49. doi: 10.1016/j.ejphar.2015.05.010. Epub 2015 May 14.

PMID:
25981305
9.

The anti-inflammatory effects of palmitoylethanolamide (PEA) on endotoxin-induced uveitis in rats.

Impellizzeri D, Ahmad A, Bruschetta G, Di Paola R, Crupi R, Paterniti I, Esposito E, Cuzzocrea S.

Eur J Pharmacol. 2015 Aug 15;761:28-35. doi: 10.1016/j.ejphar.2015.04.025. Epub 2015 Apr 28.

PMID:
25934566
10.

Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy?

Mondello P, Cuzzocrea S, Pitini V, Aloisi C, Mian M.

Acta Oncol. 2015 Jun;54(6):953-5. doi: 10.3109/0284186X.2015.1027410. Epub 2015 Apr 1. No abstract available.

PMID:
25831143
11.

Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease.

Macchi B, Di Paola R, Marino-Merlo F, Felice MR, Cuzzocrea S, Mastino A.

CNS Neurol Disord Drug Targets. 2015;14(3):313-24.

PMID:
25714978
12.

Emerging drugs for acute lung injury.

Impellizzeri D, Bruschetta G, Esposito E, Cuzzocrea S.

Expert Opin Emerg Drugs. 2015 Mar;20(1):75-89. doi: 10.1517/14728214.2015.1000299. Epub 2015 Jan 6.

PMID:
25560706
13.

The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.

Impellizzeri D, Bruschetta G, Di Paola R, Ahmad A, Campolo M, Cuzzocrea S, Esposito E, Navarra M.

Clin Nutr. 2014 Nov 27. pii: S0261-5614(14)00293-3. doi: 10.1016/j.clnu.2014.11.012. [Epub ahead of print]

PMID:
25491246
14.

Pim kinases in hematological malignancies: where are we now and where are we going?

Mondello P, Cuzzocrea S, Mian M.

J Hematol Oncol. 2014 Dec 10;7(1):95. doi: 10.1186/s13045-014-0095-z.

15.

Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.

Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M, Bruschetta G, Wallace JL, Cuzzocrea S.

J Neuroinflammation. 2014 Dec 4;11:196. doi: 10.1186/s12974-014-0196-1.

16.

Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.

Petrosino S, Ahmad A, Marcolongo G, Esposito E, Allarà M, Verde R, Cuzzocrea S, Di Marzo V.

Pharmacol Res. 2015 Jan;91:9-14. doi: 10.1016/j.phrs.2014.10.008. Epub 2014 Nov 1.

PMID:
25447594
17.

Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis.

Aiello R, Crupi R, Leo A, Chimirri S, Rispoli V, Marra R, Citraro R, Cuzzocrea S, De Sarro G, Russo E.

Behav Brain Res. 2015 Feb 1;278:155-66. doi: 10.1016/j.bbr.2014.09.042. Epub 2014 Oct 5.

PMID:
25289489
18.

A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.

Janes K, Esposito E, Doyle T, Cuzzocrea S, Tosh DK, Jacobson KA, Salvemini D.

Pain. 2014 Dec;155(12):2560-7. doi: 10.1016/j.pain.2014.09.016. Epub 2014 Sep 19.

PMID:
25242567
19.

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.

Impellizzeri D, Bruschetta G, Cordaro M, Crupi R, Siracusa R, Esposito E, Cuzzocrea S.

J Neuroinflammation. 2014 Aug 28;11:136. doi: 10.1186/s12974-014-0136-0.

20.

Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.

Paterniti I, Cordaro M, Campolo M, Siracusa R, Cornelius C, Navarra M, Cuzzocrea S, Esposito E.

CNS Neurol Disord Drug Targets. 2014;13(9):1530-41.

PMID:
25106636
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk